Korro Bio KRRO
NASDAQ KRRO
$13.18 +0.22 (+1.70%)
At close: Aug 21, 2026 · 4:00 PM EDT

Korro Bio (KRRO) Depreciation and Depletion (2018 - 2026)

Korro Bio's (KRRO) quarterly Depreciation and Depletion came in at $400000.0 in Q1 2026, down 67.35% YoY from $1.2 million in Q1 2025, and down 38.37% on a QoQ basis from $649000.0 in Q4 2025.

Korro Bio (KRRO) Depreciation and Depletion (2018 - 2026) Analysis & Trends

Korro Bio (KRRO) has 9 years of Depreciation and Depletion data on file, last reported at $400000.0 in Q1 2026.

  • Quarterly Depreciation and Depletion fell 67.35% year-over-year to $400000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 million (down 16.39% YoY) and the FY2025 annual result came in at $4.3 million, up 18.89% from the prior year.
  • Depreciation and Depletion fell to $400000.0 in Q1 2026, from $649000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $1.3 million in Q4 2024 to a low of $385000.0 in Q3 2023.
  • A 5-year average of $791647.1 and a median of $700000.0 in 2024 frame the typical range for Depreciation and Depletion.
  • Annual changes were most pronounced in 2023 — Depreciation and Depletion surged 136.21% — and 2026, when it sank 67.35%.
  • Tracing KRRO's Depreciation and Depletion over 5 years: stood at $417000.0 in 2022, then surged by 136.21% to $985000.0 in 2023, then jumped by 31.98% to $1.3 million in 2024, then tumbled by 50.08% to $649000.0 in 2025, then slumped by 38.37% to $400000.0 in 2026.
  • The last three Depreciation and Depletion figures came in at $400000.0 (Q1 2026), $649000.0 (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Korro Bio 231.77 Mn 116.73 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2026 400,000.00
Jun 30, 2026 400,000.00
Mar 31, 2026 400,000.00
Mar 31, 2026 400,000.00
Dec 31, 2025 649,000.00
Dec 31, 2025 649,000.00
Sep 30, 2025 1.20 Mn
Sep 30, 2025 1.20 Mn
Jun 30, 2025 1.20 Mn
Jun 30, 2025 1.20 Mn
Mar 31, 2025 1.23 Mn
Mar 31, 2025 1.23 Mn
Dec 31, 2024 1.30 Mn
Dec 31, 2024 1.30 Mn
Sep 30, 2024 900,000.00
Sep 30, 2024 900,000.00
Jun 30, 2024 700,000.00
Jun 30, 2024 700,000.00
Mar 31, 2024 700,000.00
Mar 31, 2024 700,000.00